PHBI Stock Analysis
PH
Uncovered
Pharmagreen Biotech Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Pharmagreen Biotech, Inc. is a biotech sciences company with specialized products and services in the booming cannabis industry. The company is headquartered in Coquitlam, British Columbia. The company went IPO on 2008-12-12. The Company’s principal business is engaged in the production of starter plantlets for the North American cannabidiol (CBD) hemp and medical cannabis industries through the application of the plant tissue culture in vitro process, Chibafreen. The company also provides laboratory-based services to the North American cannabis and agriculture sectors. The company is focused on therapeutic plants and fungi, a nutraceutical wellness product. The Company’s projects include a Live Rosin Unit, State-of-the-art Greenhouse, a Nursery Unit, Plant Tissue Culture Unit, a Live Plant Storage Unit and a DNA Testing Services Unit. The Company’s subsidiaries include WFS Pharmagreen Inc. (WFS) and 1155097 BC Ltd. (115BC).